IP Library Granted Patent US 12,060,610
Granted Patent B2
US 12,060,610 · App. 14/089,517 · Granted Aug 13, 2024

Method for evaluating and comparing immunorepertoires

Inventor: Jian Han (Huntsville, AL)
Assignee: iRepertoire, Inc.
C12Q1/6883C12Q1/686C12Q1/6869C12Q1/6881C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,060,610
App. No.
14/089,517
Granted
Aug 13, 2024
Kind
B2
Abstract

Disclosed is a method for amplifying RNA and/or DNA from immune cell populations and using the amplified products to produce an immune response profile and evaluate the possible correlation between a normal or abnormal immune response and the development of a disease such as an autoimmune disease, cancer, diabetes, or heart disease.

Claims (16)

1. A method comprising:

(a) selecting at least 2 V gene segment primers;

(b) selecting at least 2 J gene segment primers;

(c) combining the V gene segment and J gene segment primers with genomic DNA comprising rearranged nucleic acid molecules of a TCR region from lymphocytes obtained from a human or animal subject;

(d) amplifying, in one reaction, said rearranged nucleic acid molecules from said sample using said V gene segment and J gene segment primers in a first amplification reaction, thereby producing non-identical amplicons sufficient to evaluate an immune response, the non-identical amplicons representing a diversity of TCR genes;

wherein each of said at least 2 V gene segment primers is capable of annealing to V gene segment sequence and amplifying V gene segment sequence, and each of said at least 2 J gene segment primers is capable of annealing to J gene segment sequence and amplifying J gene segment sequence,

wherein each of said V gene segment primers comprises a first sequence and a second sequence, wherein said first sequence is complementary to a portion of at least one V gene segment, wherein said second sequence contains a binding site for a common primer, and

wherein each of said J gene segment primers comprises a first sequence and a second sequence, wherein said first sequence is complementary to a portion of a J gene segment, wherein said second sequence contains a binding site for a common primer;

(e) rescuing the amplicons from the first amplification reaction by dilution of the amplicons and primers from the first amplification reaction; and

(f) amplifying, in one reaction, the amplicons from the first amplification reaction in a second amplification reaction using at least one common primer which binds to the at least one common primer binding site and preserves the relative ratios of each amplicon from the first amplification reaction;

wherein diluted primers from the first amplification reaction are present during the second amplification reaction.

2. The method of claim 1 , wherein said first sequence of each V gene segment primer comprises a sequence that is complementary to a V Beta gene segment.

3. The method of claim 1 , further comprising sequencing the amplicons.

4. The method of claim 3 , wherein sequencing utilizes a set of primers that are complementary to a defined region within the amplicons.

5. The method of claim 4 , further comprising quantifying non-identical DNA sequences representing T-cell receptor Beta rearrangements among the amplicons.

6. The method of claim 5 , wherein the method allows amplification of the entire immunorepertoire of a human.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2017
From: CB BIOTECHONOLOGIES INCORPORATED
To: IREPERTOIRE, INC.
Reel/Frame 043741/0040 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2015
From: HAN, JIAN
To: HUDSON ALPHA INSTITUTE FOR BIOTECHNOLOGY
Reel/Frame 036984/0738 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2015
From: HUDSON ALPHA INSTITUTE FOR BIOTECHNOLOGY
To: CB BIOTECHNOLOGIES, INC.
Reel/Frame 036984/0757 →
Continuity (3)
Continuation 12425310 · Apr 16, 2009
Provisional Application 61045586 · Apr 16, 2008
Related Publication 20140127699A1 · May 8, 2014